Indian Pharma Defies GST Jolt, Posts 7.3% Growth in September: Report
- 16 October 2025
- 2 weeks ago
Sun Pharma Wins Interim Relief in NAXDOM Trademark Row, Delhi HC Bars Alenvision's NEXADOM Drug
- 13 October 2025
- 2 weeks ago
Sun Pharma exposed to some headline risk amid US tariff move, but with limited earnings impact
- 29 September 2025
- 1 month ago
Sun Pharma, Zydus and 3 others recall products in US
- 29 September 2025
- 1 month ago
POSITIVE Trial: Tildrakizumab Significantly Improves Quality of Life in Psoriatic Disease
- 28 September 2025
- 1 month ago
Sun Pharma Told to Limit Phase III Revefenacin Study to Triple Therapy COPD Patients
- 20 September 2025
- 1 month ago
Sun Pharma Secures Interim Court Relief In URSOCOL Trademark Dispute
- 14 September 2025
- 1 month ago
Sun Pharma Halol facility gets OAI status from USFDA
- 11 September 2025
- 1 month ago
Recent News
Madras HC grants bail to man accused of forging NE...
- 01 November, 2025
AIIMS INI SS January 2026: 4 seats added in 2 spec...
- 01 November, 2025
Treatment in Myocardial Infarction and Non-Obstruc...
- 01 November, 2025
PG medical admissions 2025 commence in Bihar, chec...
- 01 November, 2025
Assam to begin NEET PG 2025 counselling from Novem...
- 01 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.









